Literature DB >> 36171922

HITAC for ovarian malignancy---Anesthesiologist's challenge.

Shreya Das Adhikari1, Vinod Kumar2, Praneeth Suvvari3, Nishkarsh Gupta2.   

Abstract

Entities:  

Year:  2022        PMID: 36171922      PMCID: PMC9511848          DOI: 10.4103/joacp.JOACP_110_20

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN: 0970-9185


× No keyword cloud information.
Dear Editor, Cytoreductive surgery (CRS) combined with hyperthermic intra peritoneal chemotherapy (HIPEC) can improve outcomes of ovarian cancer with intraperitoneal spread by eliminating residual microscopic peritoneal disease.[1] Hyperthermic intrathoracic chemotherapy (HITAC) has been used for pleural cancers but has not been widely reported for treatment of ovarian metastases. Anesthetic management in HITAC is especially challenging because of potential complications associated with prolonged duration, one-lung ventilation (OLV), wide hemodynamic instability, cisplatin-induced nephrotoxicity, acid--base imbalance, and rapid rise in temperature.[2] We report a case of 46-year-old woman with metastatic ovarian cancer who underwent CRS with HITAC. Her pre-anesthetic check-up revealed haemoglobin of 9.6 gm% and a right-sided mild pleural effusion. Cardiopulmonary exercise testing revealed anerobic threshold (AT) of 11.5 ml/min/kg, VO2 max of 12.7 ml/min/kg, she was inducted into our routine pre-habilitation programme. After thoracic epidural and anesthetic induction, 35 French left-sided double-lumen tube was placed. Intraoperatively, analgesia was maintained with ropivacaine and fentanyl infusion. Radical abdominal hysterectomy with total omentectomy was done along with excision of metastatic deposits. Semi-open HIPEC with 100mg Cisplatin was used at 42 C for 45min. Maximum body temperature attained was 37.3°C; urine output of 2 ml/kg/h was maintained. Small rents were created in the right hemidiaphragm to achieve diffusion of cisplatin into the right thoracic cavity [Figure 1]. During 100 min. of OLV, there was no hypoxemia [Table 1]. Noradrenaline infusion was used intraoperatively, patient shifted to ICU patient was shifted to ICU and extubated next day.
Figure 1

Diaphragmatic rent to allow perfusate into thoracic cavity

Table 1

Serial perioperative Arterial Blood Gas Analysis

Post- inductionDuring CRSPre-HIPECDuring OLVPost-HIPEC (30 mins)Post HIPEC (end)
pH -7.47pH - 7.35pH -7.36pH - 7.19pH-7.23pH-7.26
pO2-234pO2-206pO2-227pO2-64pO2-189PO2-163
pCO2-35pCO2-42pCO2-37pCO2-56pCO2-34pCO2-33
HCO3-25.5HCO3-24.5HCO3-22HCO3-23.1HCO3-15.2HCO3-15.8
Lactate-0.7Lactate- 1.4Lactate-1.6Lactate - 2.3Lactate-3.3Lactate-3.6
Na-131Na-134Na-134Na - 136Na-138Na -140
K- 3.5K- 3.7K-3,7K - 4.3K-3.5K-3.8
Ca -0.99Ca -1.01Ca-1.04Ca - 0.99Ca-1.00Ca-0.91

pO2 - partial pressure of oxygen (mmHg), pCO2 - partial pressure of carbon-dioxide (mmHg), HCO3 - bicarbonate (mmol/l), Na - sodium (mmol/l), K - potassium (mmol/l), Ca - calcium (mmol/l)

Diaphragmatic rent to allow perfusate into thoracic cavity Serial perioperative Arterial Blood Gas Analysis pO2 - partial pressure of oxygen (mmHg), pCO2 - partial pressure of carbon-dioxide (mmHg), HCO3 - bicarbonate (mmol/l), Na - sodium (mmol/l), K - potassium (mmol/l), Ca - calcium (mmol/l) There are no extensive studies for the efficacy of HITAC. Small individual studies suggest that 5-year survival rate of only 5% is offered to patients who undergo debulking surgery alone for Pseudo Myxoma Peritonei (PMP).[3] In comparison, the addition of complete cytoreduction and HIPEC may permit 5- and 10-year survival rates over 75% in low-grade disease. Redo-CRS with HIPEC for disease recurrence has a demonstrated improvement in survival when compared with alternative treatments.[4] HITAC is associated with complications and a high-index of suspicion should be kept in perioperative period. Ensuring an adequate preload must be balanced against the risks of lung injury. Chances of acute kidney injury can be reduced by the maintenance of normovolaemia, forced-diuresis, and goal-directed fluid administration. Hyperthermia-related complications, including coagulation defects, direct tissue injury, acid--base disturbance, and electrolyte abnormalities can arise after the institution of heated-chemotherapeutic agents. The thoracic cavity fills with the perfusate, resulting in compression of venacavae, reduced cardiac output, mediastinal shift, and increased airway pressures further complicating the cardiovascular stability. OLV itself adds to the complications- hypoxemia, hypercarbia, labile hemodynamic parameters, acidosis, etc. Most of these patients require intensive monitoring post-operatively and are associated with protein loss, coagulation, renal, electrolyte, and glycemic dysfunction. Measures include supplementation of albumin, serial electrolytes, ABG and DVT prophylaxis. HITAC is a complex procedure wherein the physiologic challenges of major abdominal surgery, and one-lung ventilation is compounded by the thermal stress induced by peritoneal surface instillation of heated chemotherapeutic solution. A well-coordinated team of anaesthesiologists, surgeons, and intensivists with timely intervention enables excellent outcomes in such surgeries.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.

Authors:  S R Pestieau; J Esquivel; P H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2000-04       Impact factor: 5.344

2.  Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

Authors:  Konstantinos I Votanopoulos; Chukwuemeka Ihemelandu; Perry Shen; John H Stewart; Gregory B Russell; Edward A Levine
Journal:  J Am Coll Surg       Date:  2012-05-26       Impact factor: 6.113

3.  Hyperthermic intraoperative thoracoabdominal chemotherapy.

Authors:  Paul H Sugarbaker; David Chang; O Anthony Stuart
Journal:  Gastroenterol Res Pract       Date:  2012-05-10       Impact factor: 2.260

4.  Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure.

Authors:  Jalaja Koppa Ramegowda; Mohammed Abdul Salam; Vasant Nayak; Shabber Zaveri
Journal:  Indian J Anaesth       Date:  2015-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.